Literature DB >> 10679124

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

E H Warren1, M A Gavin, E Simpson, P Chandler, D C Page, C Disteche, K A Stankey, P D Greenberg, S R Riddell.   

Abstract

The mammalian Y chromosome encodes male-specific minor histocompatibility (H-Y) Ags that are recognized by female T cells in an MHC-restricted manner. Two human H-Y epitopes presented by HLA-A2 and HLA-B7, respectively, have been identified previously and both are derived from the SMCY gene. We previously isolated CD8+ CTL clones that recognized a male-specific minor histocompatibility Ag presented by HLA-B8. In contrast to the SMCY-encoded H-Y epitopes, the B8/H-Y Ag was not presented by fibroblasts from male donors, suggesting that it was encoded by a novel gene. We now report that the HLA-B8-restricted H-Y epitope is defined by the octameric peptide LPHNHTDL corresponding to aa residues 566-573 of the human UTY protein. Transcription of the UTY gene is detected in a wide range of human tissues, but presentation of the UTY-derived H-Y epitope to CTL by cultured human cells shows significant cell-type specificity. Identification of this CTL-defined H-Y epitope should facilitate analysis of its contribution to graft/host interactions following sex-mismatched organ and bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679124     DOI: 10.4049/jimmunol.164.5.2807

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

Authors:  Richard J O'Reilly; Tao Dao; Guenther Koehne; David Scheinberg; Ekaterina Doubrovina
Journal:  Semin Immunol       Date:  2010-05-26       Impact factor: 11.130

2.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

3.  Expanding the immunotherapeutic potential of minor histocompatibility antigens.

Authors:  Eric Spierings; Els Goulmy
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

4.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

5.  The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.

Authors:  Xiaomeng Hu; Simon T Kueppers; Nigel G Kooreman; Alessia Gravina; Dong Wang; Grigol Tediashvili; Stephan Schlickeiser; Marco Frentsch; Christos Nikolaou; Andreas Thiel; Sivan Marcus; Sigrid Fuchs; Joachim Velden; Hermann Reichenspurner; Hans-Dieter Volk; Tobias Deuse; Sonja Schrepfer
Journal:  Stem Cells Dev       Date:  2020-08-25       Impact factor: 3.272

6.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

Review 7.  Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.

Authors:  Xin Feng; Kwok Min Hui; Hashem M Younes; Anthony G Brickner
Journal:  Trends Immunol       Date:  2008-10-25       Impact factor: 16.687

8.  Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.

Authors:  Steven A McCarroll; James E Bradner; Hannu Turpeinen; Liisa Volin; Paul J Martin; Shannon D Chilewski; Joseph H Antin; Stephanie J Lee; Tapani Ruutu; Barry Storer; Edus H Warren; Bo Zhang; Lue Ping Zhao; David Ginsburg; Robert J Soiffer; Jukka Partanen; John A Hansen; Jerome Ritz; Aarno Palotie; David Altshuler
Journal:  Nat Genet       Date:  2009-12       Impact factor: 38.330

9.  DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

Authors:  Kellie V Rosinski; Nobuharu Fujii; Jeffrey K Mito; Kevin K W Koo; Suzanne M Xuereb; Olga Sala-Torra; James S Gibbs; Jerald P Radich; Yoshiki Akatsuka; Benoît J Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

Review 10.  Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.